BR112014030992A2 - composições compreendendo calcogenetos e métodos relacionados - Google Patents

composições compreendendo calcogenetos e métodos relacionados

Info

Publication number
BR112014030992A2
BR112014030992A2 BR112014030992A BR112014030992A BR112014030992A2 BR 112014030992 A2 BR112014030992 A2 BR 112014030992A2 BR 112014030992 A BR112014030992 A BR 112014030992A BR 112014030992 A BR112014030992 A BR 112014030992A BR 112014030992 A2 BR112014030992 A2 BR 112014030992A2
Authority
BR
Brazil
Prior art keywords
calcogenides
compositions
related methods
reduced form
methods
Prior art date
Application number
BR112014030992A
Other languages
English (en)
Portuguese (pt)
Inventor
Iwata Akiko
B Roth Mark
l morrison Michael
Original Assignee
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hutchinson Fred Cancer Res filed Critical Hutchinson Fred Cancer Res
Publication of BR112014030992A2 publication Critical patent/BR112014030992A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/24—Preparation by reduction
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/22—Alkali metal sulfides or polysulfides
    • C01B17/32—Hydrosulfides of sodium or potassium
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/007—Tellurides or selenides of metals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B19/00—Selenium; Tellurium; Compounds thereof
    • C01B19/04—Binary compounds including binary selenium-tellurium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/08—Tubes; Storage means specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
BR112014030992A 2012-06-13 2013-06-12 composições compreendendo calcogenetos e métodos relacionados BR112014030992A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261659311P 2012-06-13 2012-06-13
US201361798043P 2013-03-15 2013-03-15
PCT/US2013/045395 WO2013188528A1 (en) 2012-06-13 2013-06-12 Compositions comprising chalcogenides and related methods

Publications (1)

Publication Number Publication Date
BR112014030992A2 true BR112014030992A2 (pt) 2017-06-27

Family

ID=49758688

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014030992A BR112014030992A2 (pt) 2012-06-13 2013-06-12 composições compreendendo calcogenetos e métodos relacionados

Country Status (13)

Country Link
US (1) US20150290240A1 (cg-RX-API-DMAC10.html)
EP (1) EP2861718A4 (cg-RX-API-DMAC10.html)
JP (1) JP2015527975A (cg-RX-API-DMAC10.html)
KR (1) KR20150021509A (cg-RX-API-DMAC10.html)
CN (1) CN104471058A (cg-RX-API-DMAC10.html)
AU (1) AU2013274325A1 (cg-RX-API-DMAC10.html)
BR (1) BR112014030992A2 (cg-RX-API-DMAC10.html)
CA (1) CA2875212A1 (cg-RX-API-DMAC10.html)
HK (1) HK1209782A1 (cg-RX-API-DMAC10.html)
IN (1) IN2014MN02391A (cg-RX-API-DMAC10.html)
MX (1) MX2014014524A (cg-RX-API-DMAC10.html)
RU (1) RU2015100257A (cg-RX-API-DMAC10.html)
WO (1) WO2013188528A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015120458A1 (en) * 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
CN109650353A (zh) * 2019-01-14 2019-04-19 成都中建材光电材料有限公司 一种高纯二硫化硒的制备方法
US20230256003A1 (en) * 2020-06-25 2023-08-17 Industry-University Cooperation Foundation Hanyang University Erica Campus Pharmaceutical composition for preventing or treating sepsis containing functionalized transition metal dichalcogenide
CN114471430B (zh) * 2022-02-07 2024-01-02 天津大学 一种连续生产碱金属硫化物的装置及其合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499852A (en) * 1975-03-04 1978-02-01 Smith & Nephew Pharma Packaging
US5208336A (en) * 1990-10-19 1993-05-04 Sterling Drug Inc. Selenomerocyanines and processes for preparation and methods of use and compositions thereof
US5616214A (en) * 1995-09-12 1997-04-01 Pulp And Paper Research Institute Of Canada Determination of sodium sulfide and sulfidity in green liquors and smelt solutions
PE20001435A1 (es) * 1998-11-16 2000-12-14 Paques Bio Syst Bv Proceso para la produccion de sulfuro de hidrogeno a partir de azufre en su condicion elemental y uso del mismo en la recuperacion de metales pesados
US6579705B2 (en) * 2001-04-04 2003-06-17 Consortium Fur Elektrochemische Industrie Gmbh Process for preparing non-proteinogenic L-amino acids
KR100906949B1 (ko) * 2002-02-26 2009-07-08 가부시키가이샤 구라레 수지 조성물 및 다층 구조체
MXPA06013250A (es) * 2004-05-14 2007-02-28 Abbott Lab Inhibidores de quinasa como agentes terapeuticos.
US20080226750A1 (en) * 2006-04-20 2008-09-18 Fred Hutchinson Cancer Research Center Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse Conditions
KR101538727B1 (ko) * 2006-10-05 2015-07-22 이카리아 인코포레이티드 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
JP5083753B2 (ja) * 2007-02-26 2012-11-28 独立行政法人理化学研究所 4,5−ジメチル−[1,3]ジセレノール−2−セロンの新規製造方法
JP4028588B2 (ja) * 2007-04-27 2007-12-26 政弘 井筒 リグノセルロース系バイオマスの利用方法
EP3246034A1 (en) * 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents

Also Published As

Publication number Publication date
HK1209782A1 (en) 2016-04-08
MX2014014524A (es) 2015-02-24
KR20150021509A (ko) 2015-03-02
CA2875212A1 (en) 2013-12-19
US20150290240A1 (en) 2015-10-15
IN2014MN02391A (cg-RX-API-DMAC10.html) 2015-08-21
JP2015527975A (ja) 2015-09-24
WO2013188528A1 (en) 2013-12-19
RU2015100257A (ru) 2016-08-10
CN104471058A (zh) 2015-03-25
EP2861718A4 (en) 2016-03-23
EP2861718A1 (en) 2015-04-22
AU2013274325A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
EA201290919A1 (ru) Индазольные соединения и их применение
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
BR112012030699A2 (pt) métodos para tratar câncer de bexiga
CR20140397A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
UY34701A (es) Formas sólidas de un profármaco de nucleótidos de tiofosforamidato
CU20140025A7 (es) Pirimidinas anilladas sustituidas
MX2019011905A (es) Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica.
NI201400043A (es) 4 - fenil - piridinas sustituidas para el tratamiento de enfermedades relacionadas con el receptor de nk1
PE20160190A1 (es) Anticuerpos anti-fgfr2iiib afucosilados
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
MX366925B (es) Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
MX344222B (es) Una formulacion novedosa de naproxeno.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
MX381497B (es) Composiciones vacuna.
MX2014010563A (es) Benzodioxanos en combinacion con otros activos para inhibir la produccion de leucotrieno.
GT201400288A (es) "compuestos de fenoxietil piperidina"
BR112014014939A2 (pt) composição de tratamento de sementes
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
GT201400242A (es) "nuevos compuestos de pirazol"
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида
ECSP14027694A (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]